Abrdn Healthcare Investors Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | no data |
| Participación del CEO | n/a |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 17.8yrs |
Actualizaciones recientes de la dirección
Recent updates
HQH: Future Rate Cuts Will Help Fund's Performance
May 11HQH: Healthcare Fund With 11% Income And A High Discount
Mar 03HQH: Disappointing Track Record
Feb 04HQH: I Am Getting A 9.5% Yield On My Last Buy
Dec 19HQH: New Name But Same Risky Bets On Biotech
Nov 14HQH: Deep Discount Presents An Opportunity
Jul 03Tekla Healthcare Investors raises dividend by 7.7% to $0.42
Feb 15HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering
Dec 24Equity CEFs: What's Going On With Tekla's HQH And HQL?
Dec 08Tekla Healthcare Investors declines quarterly dividend by -2.5% to $0.39/share
Nov 16HQH: A Dividend Paymaster That Fails To Register Price Growth
Oct 20Tekla Healthcare Investors goes ex-dividend tomorrow
Aug 24Tekla Healthcare: 10% Yielding CEF Trading Below NAV
Jul 17Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Mar 30Tekla Healthcare Investors: Understanding The Mechanics Of Its 8.5% Yield
Jan 16Technical Update On HQH: Presenting An Opportunity
Oct 06HQH: Higher Valuation, But Still Appealing
Jul 31Where Fundamentals Meet Technicals: HQH (Revisited) - Yield 7.74%
Jul 08Evaluating CEFs: HQH Provides A Well-Covered Distribution In A Hot Sector
Jun 27HQH: An Overweight Biotech Fund, Paying 8%+ Distribution
Jan 14Tekla Healthcare Investors declares $0.05 special dividend
Dec 21Tekla Healthcare Investors declares $0.48 dividend
Nov 16HQH: Deep Discount Leads To High Yield
Nov 09CEO
Abrdn Healthcare Investors no tiene CEO, o no tenemos datos al respecto.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Independent Trustee | 13.3yrs | US$26.50k | sin datos | |
| Chairman and Independent Trustee of H&Q Life Sciences Investors | 24.3yrs | US$34.50k | sin datos | |
| Independent Trustee and Independent Trustee of H&Q Life Sciences Investors | 36.3yrs | US$23.50k | sin datos | |
| Independent Trustee | 14.3yrs | US$30.75k | sin datos | |
| Independent Trustee and Independent Trustee of HQL | 18.3yrs | US$28.00k | sin datos | |
| Trustee and Independent Trustee of HQL | 17.3yrs | US$24.00k | sin datos |
17.8yrs
Permanencia media
76.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de HQH son experimentados ( 17.8 años antigüedad media).